Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: Snoop Dogg releases Death Row Cannabis and Aussie player hits the German market
News
Market Highlights: Fed comments scare the market, and 5 ASX small caps to watch on Tuesday
Health & Biotech
ScoPo’s Powerplays: ASX healthcare sector Christmas rally runs out of puff
Health & Biotech
Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis
Health & Biotech
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
Weed Week: Germany’s plans to legalise cannabis rekindle North American investment spark in Europe
Health & Biotech
ASX Biotech Stocks: Estia picks up 4 new aged care homes; MGC flags positive result for long COVID symptoms
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Weed Week: Aurora Marijuanis and CBD bubble tea in Thailand
Health & Biotech
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
Health & Biotech
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
News
ASX Small Caps Lunch Wrap: Who else’s moonshot has crashed horribly today?
Health & Biotech
ASX Health Stocks: Cann’s Mildura cannabis facility gets GMP licence, unlocking export markets
Health & Biotech
Weed Week: Sydney Uni says it’s okay to CBD ‘n drive, and cannabis-infused drinks on the rise
Health & Biotech
Why millions of Aussie patients could be lining up for over-the-counter CBD… but not until 2023
News
